Loading...
•
Sep 30, 2023
Health Catalyst Q3 2023 Earnings Report
Health Catalyst reported strong financial results with revenue of $73.8 million and Adjusted EBITDA of $2.0 million, exceeding guidance. The company raised full year 2023 revenue guidance and reiterated Adjusted EBITDA guidance. Team member engagement scores measured in the 94th percentile.
Key Takeaways
Health Catalyst reported strong Q3 2023 financial results, with total revenue of $73.8 million and Adjusted EBITDA of $2.0 million, both exceeding the midpoint of their quarterly guidance. They raised their full-year revenue guidance and reiterated their Adjusted EBITDA guidance. Team member engagement scores were also high, measured in the 94th percentile.
Total revenue for Q3 2023 was $73.8 million.
Adjusted EBITDA for Q3 2023 was $2.0 million.
Full year 2023 revenue guidance range was raised.
Full year 2023 Adjusted EBITDA guidance range was reiterated.
Revenue by Segment
Forward Guidance
For Q4 2023, Health Catalyst expects revenue between $70.1 million and $75.1 million, and Adjusted EBITDA between $0.3 million and $2.3 million. For the full year 2023, they expect revenue between $291.0 million and $296.0 million, and Adjusted EBITDA between $10.0 million and $12.0 million.
Positive Outlook
- Total revenue between $70.1 million and $75.1 million for Q4 2023.
- Adjusted EBITDA between $0.3 million and $2.3 million for Q4 2023.
- Total revenue between $291.0 million and $296.0 million for the full year 2023.
- Adjusted EBITDA between $10.0 million and $12.0 million for the full year 2023.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...